Get the latest Science News and Discoveries

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial - EurekAlert!


Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of EurekAlert

EurekAlert

Photo of Lung01 trial

Lung01 trial

Photo of high response rate

high response rate

Related news:

News photo

Log In - EurekAlert! - EurekAlert!

News photo

Breakthrough in battery management: New AI model enables more accurate state of charge estimation - EurekAlert!

News photo

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease - EurekAlert!